Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017

Amphastar Pharmaceuticals (AMPH) PT Raised to $24 at Needham & Company

March 13, 2018 6:31 AM EDT

Needham & Company raised its price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $24.00 (from $23.00) while maintaining a Buy rating following Q4 results.

Analyst Serge Belanger commented, "AMPH reported a 4Q17 financials that mostly met or exceeded Street Consensus. Since AMPH saw minimal benefits... More